MUMBAI, May 13, 2025 — Syncom Formulations (India) Limited (BSE: 524470, NSE: SYNCOMF) has notified the stock exchanges of its upcoming Board Meeting scheduled for Monday, May 19, 2025 at 4:00 PM IST, to be held at the company’s corporate office in Indore, Madhya Pradesh.
Key Agenda
The meeting will focus on the following core business matters:| Agenda Point | Description |
|---|---|
| a. | Approval of Standalone and Consolidated Audited Financial Results for Q4 and full year ended March 31, 2025 |
| b. | Consideration and acknowledgment of the Audit Reports on both Standalone and Consolidated results |
| c. | Discussion on other incidental business matters |
Compliance and Disclosures
- The announcement complies with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015, and is aligned with SEBI (PIT) Regulations.
- The company has also confirmed the closure of the trading window, per SEBI circular dated July 19, 2023.
- Filing of this corporate announcement in XBRL format is currently underway.
Outlook
The results from this Board Meeting will provide insights into Syncom Formulations’ operational and financial performance for FY2024- 25. Stakeholders and investors will closely watch for key indicators on revenue growth, profitability, and strategic direction.For further updates, the audited results and related disclosures will be hosted on the company’s official website and shared on the BSE and NSE platforms.